es
Feedback
GiT Updates and More

GiT Updates and More

Ir al canal en Telegram

Gi doctor with interests in endoscopy, gut health, liver & medicine in general.

Mostrar más
5 332
Suscriptores
+324 horas
+287 días
+9630 días
Archivo de publicaciones
photo content

photo content

photo content

✅The Most Common Blood Pressure Medications in the ARB Group ✍️How to Choose the Most Suitable Medication for Each Medical Condition. 🔲First: Losartan: This is the best choice for patients with gout because it reduces uric acid levels. It is also preferred if the goal is to reduce the risk of stroke, especially in patients with a history of transient ischemic attacks (TIA) or previous strokes. 🔲Second: Valsartan and Candesartan: These two medications are ideal for patients with heart failure (HFrEF) because they reduce heart-related mortality and hospital admissions. 🔲Third: Irbesartan: It is recommended for cases of diabetic kidney disease or chronic kidney disease (CKD) because it helps slow the progression of kidney diseases. 🔲Fourth: Telmisartan: Particularly effective for patients at high risk of cardiovascular diseases or metabolic syndrome, as it improves the body's sensitivity to insulin. 🔲Fifth: Olmesartan: Known for its strong effect in lowering blood pressure, making it an excellent choice for cases of resistant hypertension. 🔲Sixth: Eprosartan: The best option for patients with excessive sympathetic activity, such as those with blood pressure fluctuations or rapid heartbeats, as it provides effective inhibition of the sympathetic system.

photo content

photo content

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

photo content

Autoimmune hepatitis
Autoimmune hepatitis

photo content
+3

photo content

photo content

photo content

photo content

photo content

photo content

photo content

AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis

AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis